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Abstract 
This paper gives a review on an efficient microtechni-
que (Gel Crystallization Method; GCM) which quantifies 
crystal growth in gel matrices, and its application to re-
search into urinar y stone formation. Relative crystal 
growth rates (Ver) of calcium oxalate hydr ates (CaOx) were 
determined by simultaneous multiple measurement s in 96-
well microplat es using computer controlled microscopic 
photom etr y. Efficiency: 120 kinetic measurements/h; 
imprecision : <2% at standard conditions. The method was 
applied to study the effects of diverse small-ionic and 
macro molecular constituents of human urine on the crystal 
growth rate of CaOx. The 'inhibitory activity ' of urine 
cou ld be evaluated by comparison of the Ver measured in 
native and corresponding artificial samples. Macromolecule s, 
a t physiologic al concentration, played only a minor role as 
inhibitors in the model under regard. The GCM was 
employed to s tudy the in-vivo effects of different thera -
peutic measures on CaOx growth in urine of normal volun-
teer s. While the application of alkali citrate resulted in a 
>7 0 % decline of Ver, no beneficial effects could be found 
with three magnesium compounds, and a dietary fiber 
preparation . In a study including 20 male recurrent CaOx 
stone form ers and 29 well-matched controls, among all 
parameters under investigation , the Yer showed the most 
significant difference (p<0.00 I) between the both groups . 
In conclusion, the method described here has been proven 
to be of high value with respect to a series of applications 
in the study of urolithiasis. However, though the crystal 
growth rate of CaOx is of undoubted importance in stone 
genesis , other phenomena , like crystal agglomeration and 
adhesion on surfaces, must yet be taken into account as 
causative factors . 
Key words : 
Calcium oxalate uroli thiasis, Crystal growth, Crystals, Gel 
matrices, Human urine, Hydrated calcium oxalate, Inhibition, 
Microscopic photometry, Micro technique 
Address for correspondence: 
W. Achilles 
Universitaetsklinikum Marburg , Urologie / Klin.Forschung 
Baldingerstr. D-3550 Marburg/Lahn, Germany (West) 
Phone No . (6421) 28-2203 
1001 
Introduction 
Conventional determinations of growth rates of crys-
tal phases relevant in urinary stone formation usually are 
carried out in aqueous solutions or crystal suspensions 
(Fleisch, I 985; Baumann, I 988). However, urinary stones 
form via the growth of crystals fixed in the urinary tract 
(Finlayson, I 982). Corresponding to the results of Iwata 
et al. (I 985 , I 986 , I 989), this growth occurs in a gel-like 
state. The gel is formed by a mucinous macromolecular 
layer, which encrusts on the surface of the calculi forming 
the well-known organic stone matrix. From this point of 
view, it seems to be reasonable to study the growth of 
crystals relevant in urolithiasis in gel matri ces rather than 
in so lution s or suspensions, respectively . Moreover, con-
ventional methods for the determination of crystal growth 
rates are time-consuming and, as a rule, require large test 
vo lumes . Often, urine has to be highly diluted in order to 
test the so-called inhibitory activity because a direct appli-
cation of the methods to undiluted urine is not possible 
(F leisch, I 985; Baumann, 1988) . 
Taking into account these aspects of crystal growth 
experiments in research into urinary stone formation, we 
have developed a photometric micromethod (Gel Crystalliza-
tion Method; GCM) for the efficient determination of 
relative crystal growth rates in gel (Achilles, 
I 984, I 985 , I 989) . It has been aimed to overcome the 
disadvantages referred to above or to complement the 
methods hitherto practiced. 
This paper reviews the experimental design of the 
technique and its principal applications to the research of 
urinary stone formation with respect to calcium oxalate 
(CaOx) hydrates. 
Methods and Materials 
Description of the Method 
From the two components of a precipitating solid 
phase (e.g. calcium oxalate), one is dissolved as a soluble 
compound (e.g. sodium oxalate) in a sol. By addition of a 
small amount of the counter-ion (e.g. as calcium chloride), 
sufficient supersaturation is gained in order to generate 
seed crystals. Subsequently, the sol is pipetted into the 
cavities of a 96-well microplate, thus forming a horizontal 
gel matrix with seed crystals. Crystal growth, which occurs 
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by one-dimensional double diffusion in the gel matrix, is 
started by pipetting a suitable solution containing the 
counter ion (i.e. calcium in artificial or natural urine) onto 
the gel phase. Subsequently, growing crystals are followed 
by vertical light path photometry as a function of time. 
The dark field of the microscope producing scattered light 
has been proven to be the most useful mode of measure-
ment. High efficiency and precision in measurements is 
achieved by: (I) a strictly s tandardized procedure of gel 
preparation ; (2) multiple sample handling of small volumes; 
(3) fast sequential photometr y in 48 (-96) positions of the 
microplate, repeating the measuring cycle in prescribed 
interval s up to 15-30 times , thus collecting time-dependent 
measuring data; (4) the application of a computer-control-
led microphotometer, and (5) current reference to a kinetic 
standard taking into account blank values. The principle of 
the method is demonstrated in Figure I. 
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Figure I: Principle of the optical micromethod for the 
determination of relative crystal growth rates in gel 
matrices (Gel Crystallization Method ; GCM)_ 
Measuring Device 
An automated microphotometric system for transmit-
ted light was used comprising the following parts : a) inver-
ted microscope IM35 equipped with power-stabilized halo-
gen light source HBI 00, rapid (50 µm step) scanning stage 
adapted to 96-well microplates, and photometer SFD; b) 
electronic control unit MPC 64; c) camera Contax RTS and 
video camera LDH 2107 (Philips) for the observation and 
evaluation of crystal images within the gel; and d) on-line 
microcomputer HP 98 I 6S for photometer control, aquisi-
tion, processing and display of data. Computer programs 
were written in HP-BASIC 5 .0 . The equipment is shown in 
Figure 2. 
Ver , the parameter of relative crystal growth, is defi-
ned as the ratio of the maximum slope of any measuring 
curve to the maximum slope of the current standard curve. 
In case of quasi-linearly shaped curves, slopes may be calcu-
lated by linear regression analysis. In other cases, like 
hyperbolic or sigmoidal shapes, a five-parametric nonlinear 
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Figure 2: Computer controlled microphotometric system 
for multiple determinations of crystal growth rates in gel 
matrices (Gel Crystallization Method; GCM) comprising the 
following parts : Inverted microscope IM 35 with pho-
tometer and scanning stage adapted to microplates, stabili-
zed power supply, electronic control unit, video camera 
(Carl Zeiss, W.-Germany) and computer HP 98 I 6 S. 
fit corresponding to Equation I could be successfully 
applied. 
where: !(!) ... measuring light intensity; L..time of actual 
measurement; te ... time of final measurement; Kn.,.coef -
ficients to be calculated by regression analysis (Schalk and 
Achilles, unpublished results) . 
Materials 
For the determination of crystal growth rates of 
CaOx, the gel phase consisted of 0.5 % (w/w) agar-agar, 2 
mM sodium oxalate, I mM sodium azide, 0.5% (w/w) 
glycerol, and about 0 .05 mM CaCl2. It was prepared corre -
spo nding to the following prescription : 250 mg of dry gel 
substance (Ca-free agar-agar, preferably "high gel strength " 
or "for electrophoresis", SERVA, Heidelberg, Germany), 
250 mg glycerol, 0.05 mmol sodium azide, and 0 . 1 mmol 
so dium oxalate were completely dissolved at 980C in water 
( final volume: 50 ml). To produce seed crystals, the solu-
tion was cooled down to 60°C and a bolus of 0 .5 ml 
5 mM CaC12 was added during stirring the solution on a 
magnetic stirrer (1500 rpm)_ Subsequently, portions of 0.1 
ml/cavity of the hot sol were quickly pipetted (diluter 
Tecan 450) into the wells of prewarmed microtiter plates 
(polystyrene; flat bottom) and cooled off to room tempe-
rature. Plates were stored in moist chambers and could be 
used up to 6 weeks . 
A solution of the following composition was used 
as current measuring standard (total concentrations in 
parentheses given in mM): Na(l 31 ), K(40) , NH4(25) , 
Ca(4.0), Mg(3.0), phosphate(20), sulfate(l 5), citrate(2.0), 
chloride(l 4 9), urea(250) , pH 6.0 . This was also employed 
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as a reference solution ('artificial urine') in a series of 
experiments to measure effects on crystal growth. Though 
its composition does not correspond to the mean values of 
24-h collections of a well-defined population of volunteers, 
concentrations are in the physiological or pathophysiologi-
cal range. The quantity of its crystal growth parameter Ver 
(=I) reflects conditions relevant to urine of CaOx stone 
formers . As a rule, substances to be tested with respect to 
their effects on Vcr(CaOx) had been dissolved in this solu-
tion . Principally, measurements in undiluted native urine 
were performed after thawing of frozen samples and centri-
fugation (Achilles and Ulshafer, I 986) . All measurements 
were carried out at controlled room temperature 
(23±1 OC) . 
Statistical Evaluation 
Statistical results mentioned in this paper predomi-
nantly refer to the significances of differences of parame-
ters. Principally, they were calculated as follows . Distribu -
tions of paired or unpaired data were evaluated using nor-
mality tests. Corresponding to the distributions assessed 
(normal , symmetrical, others) appropriate tests of signifi-
cance were chosen (paired t-test, Wilcoxon rank test, or 
sign-test for paired data, and expanded t - test , Mann-Whit-
ney test or median test for unpaired data) . 
Methodological Results 
The empirical parameter Ver determined by this method 
reflects the thermodynamic as well as kinetic effects of the 
constituents of a solution on crystal growth within the gel 
matrix . Provided that a certain limit of supersaturation is 
not exceeded, the seeded gel matrix ensures the measure-
ment of pure crystal growth. Simultaneous nucleation may 
be unambigeously excluded if crystallization experiments 
are carried out within the limits of metastability of the 
system under regard . Metastability limits may be estimated 
by precipitation experiments in an unseeded gel using corre-
sponding supersaturations (Burk and Achilles, unpublished 
findings). 
Seed crysta ls of CaOx were produced by pre-precipi ta-
t ion in the sol state in order to provide a regular distribu-
tion of crystalline particles within the gel matrix. Predomi-
nantly, they consisted of monoclinic, coffin-shaped calcium 
oxalate monohydrate and some of them grew up to a 
maximal size of 5 µm. From optical microscopy, minor 
formation of calcium oxalate dihydrate could not be exclu-
ded. The major part of seeds had a submicroscopic size , 
which could be derived from the number of countable 
crysta ls before and after precipitation from Ca-conta ining 
solutions or urine. Figure 3 shows a series of typical 
images of growing CaOx crystals as observed with the 
dark-field mode of microphotometric measurement (scatte-
red light). 
Apart from the thermodynamic and kinetic effects of 
solutes referred to above, the absolute slopes of crystal 
growth curves depend on a number of conditions, e.g ., 
diffusion coefficients, temperature, number and size of seed 
crystals . Therefore, a strictly standardized procedure is 
necessary in order to prepare the gel matrix. In particular, 
this refers to the critical generation of seed crystals. 
Figure 3: Scattered light image (x8) of CaOx crystals 
growing in gel of a single cavity of a microtiter plate at 
different times of reaction (standard conditions; dark field 
mode of measurement). 
However. despite some differences of slopes of meas-
uring curves between series, slopes referred to that of a 
defined standard gave highly reproducible results. The 
imprecision (coefficient of variation within a series) of the 
crystal growth parameter Ver at standard conditions is 
<3 % for sing le determinations, and <2 % for mean values 
from four-fold determinations as they were usually carried 
out. As an example, Figure 4 demonstrates 44 original 
crystal growth curves of CaOx and four water blanks 
resulting from simultaneous multiple measurement with the 
standard solution mentioned before . Intensity of scattered 
light (as arbitrary units) , arising from the dark field mode 
of measurement, is plotted as a function of measuring time . 
An additional examp le of measurements is shown in Figure 
5 . The crystal growth curves plotted here correspond to a 
simultaneous multiple measurement in 48 positions of a 
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Figure 4 : GCM. Typical graphical protocol of 44 simulta-
neously registered crystal growth curves of CaOx from the 
same standard solution and 4 blank values (water) as used 
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Figure 5: GCM. Typical curves of crystal growth of CaOx 
(AD-units vs. measuring time) as obtained from artificial 
urine samples: 4-fold determinations in solutions with 
different total calcium concentration (Car 2-8 mM). 
Gelphase: 0.5% agar-agar; 2 mM Na oxalate; 0.05 mM 
CaCl2 . Mode of measurement: dark field. 
The efficiency of the meihod is high. Applying the 
actual procedure, 40 crystal growth curves may be regis-
tered simultaneously by I 5 cycles of measurements, corre-
sponding to at least I 20 kinetic determinations per hour. 
As a rule, a gel volume of I 00 µI and a measuring volume 
of 200 µI of solution were used per well of a microplate. 
For these reasons, the GCM is suitable for larlle-scale 
measurements, and may be applied clinically (Achilles and 
Ulshafer, I 986; Achilles, I 989) . 
In some parallel experiments, we tested the influence of 
different gel matrices (agar-agar ; various sorts of agarose, 
0.3-1.0 g/100ml; and gelatine 5g/l 00 ml) on Ver using 
artificial and native urine samples . Relative crystal growth 
rates referring to the same solutions but different gels 
agreed quite well (r>0 .98) (Achilles and Ulshafer, 1986). 
Apart from the CaOx system dealt with here, the GCM 
could also be applied to the quantification of growth of 
other crystal phases. Detailed results on crystallization 
experiments in gels with octacalcium phosphate and barium 
sulfate will be published elsewhere . 
Effects of Calcium. Magnesium, Citrate and pH 
Urinary calcium, magnesium, citrate, and hydrogen ion 
concentrations are known to affect the crystal growth of 
CaOx in different ways . Optimal alterations of the output 
of these constituents in urine are aimed by several pro-
phylactic measures in order to prevent recurrent stone 
formation. However, their interrelationship with respect to 
the net effect on the crystal growth rate of CaOx has not 
been investigated yet. 
Starting from the standard solution referred to above, 
we studied the crystal growth rate, Ver, as a function of 
total concentrations of calcium (Car), magnesium (Mgr), 
citrate (Citr), in addition to pH. In a first set of experi-
ments, each parameter was varied in the solution whereas all 
others were kept constant at their normal values (Achilles 
and Ulshafer, I 985 b). The corresponding results are 

















Figure 6: Relative crystal growth rate of CaOx (Vcr(CaOx): 
_) and corresponding calculated, normalized supersatura-
tion within the gel phase (S/SN:---) as a function of differ-
ent parameters in artificial urine as indicated in the figure . 
Cr/CN: normalized, total concentrations of Ca, Mg, and 
citrate . pH-values at the 5 marked points (from left to 
right) : 5 .4, 5.7 , 6.0, 6.3 and 6.6. Each variation of a 
single parameter was carried out keeping all the others at 
constant values. The curve marked by Crs refers to the 
simultaneous variation of all constituents of the artificial 
urine at constant pH (simulation of dilution). 
Here, with the exception of pH, independent parameters are 
expressed in terms of normalized concentrations (Cr/CN), 
which seems to be reasonable especially from a physiological 
point of view. CN refers to the total concentration of the 
standard solution of mean (normal) composition as de-
scribed above . In order to compare the crystal growth rate 
with the thermodynamic driving force of the process under 
regard, corresponding normalized supersaturations within 
the gel phase (S/SN) were estimated by computer calculation 
of complex chemical equilibria (Achilles and Ulshafer, I 985a) 
corresponding to the following definition (Equation 2): 
(2) 
where S=supersaturation at actual conditions; SN=supersa-
turation at normal conditions, i.e., at concentrations of the 
standard solution; AP=activity product at actual conditions; 
APN=activity product at normal conditions; Ksp=solubility 
product of CaOx within the gel phase. S/SN is shown along 
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Figure 7: Effects of pH and total concentrations of calcium (Car), magnesium (Mgr), and citrate (Citr) on the relative 
crystal growth rate of CaOx (Ver). Variations of parameters were carried out in artificial urine which was basically composed 
as outlined in 'Materials'. Normal values of the parameters under regard were : Car=4 mM, Mgr=3 mM, Citr=2 mM, pH=6, 
Vcr=l .O. Corresponding variations are indicated in Figures (a)-(f) as 'var .' . Each parameter was varied while keeping all others 
at their normal or indicated values . The curves shown in each figure were calculated by non-linear regression analysis from all 
experimental values corresponding to Equation 3. 
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Continuing this study, the dependence of Ver on its 
effectors Ca, Mg, Cit, and pH was further determined by 
their extended variations . The results are summarized gra-
phically in Figure 7(a-f) . In contrast to the illustration in 
Figure 6, abso lute quantities of the independent variables 
were used instead of normalized ones (Achilles et al., I 989b, 
and unpublished findings). 
From these data, an empirical mathematical relationship 
between Ver and the effectors under consideration could be 
derived using a model of non-linear regression analysis 
(Equation 3) (Achilles et al. , I 989b, I 990) . 
Ver= A/B (3) 
with A= I + P101[(CaT/CaN)-I) + P201[(CitT/CitN)-ll 
+ P30 I [(pH/pHN)-1) + P 40 I [(Mgr/MgN)-1 J 
+ P23 i[(CitT/CitN)-1 l [(pH/pHN)-1 l 
+ P24 i[(CitT/CitN)-1 l [(Mgr/MgN)-1 l 
+ P441[(MgT/MgN)-tJ 2 
and B = I + Pt 02[(CaT/CaN)- I l + P202[(CitT/CitN)- I) 
+ P302[(pH/pHN)- I J + P 402[(Mgr/MgN)- I J 
+ P232[(CitT/CitN)-I ][(pH/pHN)-1 J 
+ P242[(CitT/CitN) - l ][(Mgr/MgN)-I l. 
where 
P101= 1.780 ; P201=-0.247 ; P301= -0.6SS ; P401=-0 .041; 
P23 t =-0 .543 ; P24 t = 0.041 ; P 44 t =-0.021 
Pt oy-0 . 125 ; P20Y 0.20 I; P302= 0 .792 ; P 40Y 0.1 SI; 
P23y 0 . 1 23; P24y -0 .036 . 
CaN = 4 mM; CitN = 2 mM, pHN = 6 .0, MgN = 3 mM. 
The symbols used in this equation have the following 
meaning : Pxyz· ··coefficients mathematically determined; 
pH ... actual pH; pHN.--normal pH; CT ···actual total concen-
tration ; CN.--normal total concentration . Equation 3 could 
be successfully applied to elucidate the effects of an alkali 
citrate therapy on the crystal growth rate of CaOx in 
human urine (Achilles et al., I 990) . 
The results demonstrated above may be summarized 
and interpreted as follows (Achilles et al. , I 989b) : Among 
all the parameters investigated, calcium exerts the most 
pronounced effect on Ver. From the relationship 
Vcr=f(CaT) (Figure 7a-c), i.e. from the section point with 
the Caraxis (Vcr=0), the apparent solubility product of 
CaOx referring to the gel phase could be derived 
(Ksp(CaOx,gel)= 3 .3xl o-8 mo12/f2) . It is about one order 
of magnitude greater than the Ksp determined in corre-
spond ing aqueous solutions (2-Sxl o-9 mol2/f2; Tomazic 
and Nancollas, I 979, I 980). Effectors of crys tal growth 
may decrease the slope of the function Vcr =f (CaT) and, 
simultaneously, shift the section point on the Caraxis 
(Figures 7a-c). While the first effect could be predominantly 
accounted for by a pure kinetic action, the latter one 
should refer to a reduction of crystal mass, which , as a 
rule , might be explained thermodynamically . 
Citrate cou ld be shown to decrease the crysta l growth 
of CaOx effective ly. As may be derived from Figures 6 and 
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7a, the effect is of 'mixed' thermodynamic and kinetic 
origin, i.e., it is caused by ion-pair formation wit lh Ca and 
inhibition via adsorption onto the crystal surface . 
Magnesium affects the crystal growth by two counter-
acting mechanisms . It reduces the Ver by ion-pair formation 
with oxalate and diminishes the inhibiting effect of citrate 
(and other anions in urine) by corresponding interactions. 
However, the net effect depends on the actual co ncentra-
tions of the relevant urinary constituents . T1hus, for 
example at high urinary citrate, increasing Mg may have no 
remarkable influence on the crystal growth or may even 
increase Ver, as demonstrated in Figure 7e . 
In the system under regard, increasing pH causes a 
decline of the Ver. Predominantly, this effect must be 
attributed to an indirect mechanism of deprotonation of 
other effectors of crystal growth. This will be explained 
later on in this paper. 
Simultaneous alterations of different paramet e rs acting 
in the same direction reducing crystal growth may be very 
effective with respect to the prevention of st o ne recur -
rence . An example will be shown below . 
Effects of Major Urinary Constituents (Achilles et al., 
unpublished findings) 
Sodium, potassium, ammonium, chloride, sulfate , and 
phosphate mainly affect the ionic strength, and thus 
acti vity coefficients , of human urine and have some influ -
ence on the complex chemical equilibrium . Via these thermo-
dynamic mechanisms, the crystal growth rate of CaOx may 
be altered. Moreover, direct or indirect kinetic effects of 
these components on the crystal surface might be of some 
import ance. In ord er t o investigate these phenomena , 
variations of the ions referred to above were carried out 
similarly to those described above . The Ver was determined 
as a function of these parameters and compared with corre-
sponding degrees of the initial , normalized super saturation 
within the gel phase, S/SN (see Equation 2) . 
In a fir s t set of experiments, NaCl, KCI and NH4CI 
respectively were added to a simulated urine containing SO 
mM of Na(+) as basic (initial) concentration. Increasing the 
concentrations of the electrolytes added up to 400 mM, 
the crystal growth rate dropped nearly linearly. The results 
are demonstrated in Figure 8 . A quite parallel course could 
be found between Ver and S/SN. However, the different 
effects caused by the different electrol y tes could not be 
accounted for by the thermodynamic model used . This issue 
needs further investigation. 
In a second series of experiments, total sulfate was 
varied in the standard solution from 0 to 55 mM, which 
caused a decrease of the crystal growth rate from I . IS to 
0.5. Simultaneously, S/SN dropped from I.I to 0.7 . It may 
be concluded that sulfat e decreases Ver predominantly via 
its ion pair formation with Ca(2+). However, a small 
additional kinetic effect of inhibition must be taken into 
account. 
In a third set of measurements, Ver and S/SN were 
determined as a function of total phosphate (0-40 mM) and 
pH (S-6 .S) . Again, corresponding variations were carried 
out at standard conditions. As may be seen from Figure 9, 
both parameters cause a considerable decrease of the crystal 
growth rate while, in parallel, there is only a relatively small 
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Figure 8: Effects of different electrolytes on the relative 
crystal growth rate of CaOx, Ver, in artificial urine. The 
measuring parameter Ver (-) is compared to the calculated 
normalized supersaturation of CaOx within the gel phase, 
S/SN (---). Total concentrations of NaCl, KCI, and NH4CI 
were added to artificial urine (pH 6.0) with an initial NaT 
of 50 mM. The letters at the curves correspond to the 
addition of the following electrolytes: A=NaCI, B=KCI, 
C=NH4CI (Ver); a=KCl,NH4CI, b=NaCI (S/SN). 
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Figure 9: Effects of pH (abscissa) and total phosphate 
concentration (indicated in the figure) on the relative crys-
tal growth rate of CaOx in artificial urine. The measuring 
parameter Ver (_) is compared to the calculated normali-
zed supersaturation of CaOx within the gel . S/SN (---) . 
------------------ ----------------------- -------- ------------ ----
or even negligible change of S/SN . The following may be 
concluded from these results : Firstly, phosphate decreases 
the crystal growth rate of CaOx chiefly by a real kinetic 
inhibition effect which can be attributed to the species 
HPO4(2-) (and PO4(3-)) . Secondly, the decreasing effect of 
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pH on Ver in the syste m under regard is mostly of indirect 
kinetic nature. It may be accounted for by the species 
HPO4(2-) (PO4(3-)) and Cit(3-). In general, the major 
urinary constituents regarded here may considerably contri-
bute to the crystal growth of CaOx in human urine via 
different mechanisms. 
Effects of Other Low-molecular Weight Compo nents of 
Human Urine and Artificial Substances (Achilles et al., 
unpublished findings) 
As will be shown below, crystal growth rates of CaOx 
measured in natural human urine differ from correspond ing 
values of artificial urines of comparable composition re-
gard ing their main components. In order to account for a 
potential additional inhibiting activity, the following sub-
s tances occuring in natural human urine were tested: various 
amino acids and organic acids, bile acids, creatinine, urate, 
ascorbate, pyrophosphate, and isocitrate. Only a few of 
them were found to exert significant inhibition within their 
range of physiological concentration . They are listed in the 
upper part of Table I . 
Table I . Influence of urinary constituents and other sub-
s tances on the relative crysta l growth rate of CaOx (Ver) in 
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1.0 - 10 
l.O - 10 
1.0 - 10 
0.01 - 0 .1 
0 .05 - 1.0 
0.05 - 1.0 
Inhibition 
(%) 
3 - 15 % 
4 - 17 % 
I 8% 
I - 9 % 
9 - 40 % 
7 - 36% 
4 - 14 % 
0 - 5 % 
45-100 % 
22 - 80 % 
22 - 83% 
In a further set of experiments, several artificial sub-
stances of potential therapeutical or theoretical interest in 
the prevention of CaOx urolithiasis were investigated by 
the GCM (Table 1; lower part) . A comparison of the action 
of citrate, isocitrate, pyrophosphate and phosphocitrate on 
the Ver is demonstrated in Figure 10. 
Effects of Urinary Macromolecules 
Macromolecules have long been supposed to influence 
crys tal growth processes relevant in urinar y stone forma-
tion (e.g.: Bowyer et al., 1979; Edyvane et al, 1987; 
Lanzalaco et al., 1988 ; Robertson and Scurr, 1986; Scurr 
and Robertson, l 986a,b). However , data in the literature 
on this topic have been contradictory . Therefore, we 
tested the macromolecules chondroitin sulfates A,B,C, 
heparan sulfate, hyaluronic acid and human serum albumin in 
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Figure I I : Effect of human serum albumin (HSA), hyaluro-
nic acid (HYA), chondroitin sulfate A,B,C (CHON A,B,C), 
and heparan sulfate (HS) on the relative crystal growth rate 
of CaOx in artificial urine (standard solution). 
In the concentration range 1-1000 mg/I, most of the 
substances caused only small effects on Ver (<5 % inhibi-
tion) (Figure I I) . 
In further experiments, Tamm Horsfall Mucoprotein 
(THMP) and a macromolecular fraction from human urine 
(MMFU; MW>5000d) were tested at their physiological 
concentrations in the standard solution. THMP was prepa-
red from pool urine of stone patients corresponding to the 
prescription of Tamm and Horsfall (I 950). Urinary macro-
molecules were isolated by ultrafiltration from 24-h urine 
collections of calcium oxalate stone formers and normal 
controls. For this, low molecular weight components of 
the native urine samples were washed out and substituted 
by standard solution. Corresponding to the molecular 
weight cut-off of the ultrafilter used the fractions con-
1008 
tained pools of macromolecules >5000d at their individual, 
original urinary concentrations. No significant effect on the 
Ver of CaOx could be detected with THMP (17-170 mg 
protein/I). MMFU from natural urine washed into the 
standard solution decreased the Ver from I .0 to 0. 97±0.03 
(group of 25 recurrent CaOx stone formers) and to 
0 .95±0 .03 (group of 25 normal controls) (Achilles et al., 
I 989a; and unpublished findings) . 
Thus, in the model of crystallization under regard and 
referring to simulated urinary conditions, soluble urinary 
macromolecules do not exert significant effects on the 
crystal growth of CaOx in the gel matrix. However, at 
higher concentrations (> I g/1), as relevant in stone 
matrices, they might play a role as inhibitors of crystal 
growth thus protecting the urinary tract from pathological 
mineralization. 
Measurement of Crystal Growth of CaOx in Natural Urine 
Samples 
The GCM may be directly applied to measure the rela-
tive crystal growth rate of CaOx in natural urine samples 
(Achilles and Ulshafer, I 986) . However, with regard to this 
application, some principal problems or limitations must be 
taken into account. As a rule, native urines are metastable 
solutions with respect to some crystal phases. Thus, 
especially in 24-h collections, CaOx hydrates, as well as uric 
acid, may be partially or nearly completely precipitated 
before measurement. In urinary samples with pH>6.4, 
calcium phosphate phases and struvite potentially may 
precipitate, thus decreasing particularly total calcium, which 
leads to artefacts in the determination of the Ver of CaOx. 
Bacterial contamination is especially dangerous in this 
respect. From a practical point of view, samples of urine 
can be stored in a frozen state (-20 to -80°C) up to meas-
urement. Then, after thawing, more than 90% of total 
oxalate is precipitated (Limmer and Achilles, unpublished 
findings). The small portion of oxalate remaining in solu-
tion has practically no effect on the measuring parameter 
Ver when determined in the supernatant of the samples 
after centrifugation . The lack of calcium by precipitation of 
CaOx may account for a maximum of I 0% decrease of the 
Ver. Since this error has a similar amount in all samples, 
especially in intraindividual measurements at different time, 
it may be neglected for practical purpose. However, urinary 
samples at pH>6.4 should be checked analytically for the 
potential loss of Ca by phosphate containing precipitates . 
Eventually, solids may be dissolved by acidification of the 
urine, and measurement of crystal growth can be carried 
out in metastable solutions after adjustment to original pH. 
The GCM has been applied to measure the crystal 
growth parameter Ver in native urine samples in clinical 
routine in our laboratory for some years. Results on 
measurements in urine samples of stone formers and normal 
controls, as well as on the effects of different therapeutical 
measures, will be dealt with later on in this paper. 
In order to assess whether natural urine samples would 
contain additional 'inhibitory activity' of CaOx crystal 
growth compared to artificial urines of comparable known 
composition, we carried out the following experiment 
(Limmer and Achilles, unpublished findings). 60 samples of 
24-h native urines (NU; supernatants after centrifugation) 
were analyzed for pH and total concentrations of calcium, 
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magnesium, sodium, potassium , ammonium , oxalate, sul-
fate, phosphate, chloride, citrate and isocitrate . Artificial 
urines (AU) were composed which had the same composi-
tion with respect to these constituents analyzed. The Ver 
was measured in parallel in all samples under regard. The 
results are shown in Figure I 2. The regression line is 
described by the relationsship Vcr(AU)= a·Vcr(NU)+b, with 
a= I. IO and b=0.17 . The deviation of the factor a= I. I of 
this equation from the theoretical value a= I may be clearly 
interpreted by the presence of pyrophosphate , hippurate, 
glucuronate and macromolecules in the native urines, which 
were not included in the artificial samples. This may be 
derived from the results on the effects of these inhibitors 
in simu lated urine as outlined before. However, the con-
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Figure 12: Comparison of crystal growth rates of CaOx, 
Ver, measured in 24-h natural urine collections (NU) from 
unselected stone formers, and in correspondingly com po-
sed, artificial urine samples (AU). 
Crystal Growth Rates of CaOx in Urine of Recurrent Stone 
Formers and Normal Controls 
In order to evaluate the role of crystal growth inhibi-
tion in the genesis of CaOx urolithiasis, we determined the 
Ver of CaOx and a number of other parameters in defined 
urinary fractions of well-matched groups of stone formers 
and controls (Achilles et al., I 991 ). The following volun-
teers were included in the study : 20 male normocalcaemic, 
recurrent CaOx stone formers (prevalence: more than 2 
stones) with normal renal function, aged 40-50 years, and 
29 age-matched healthy men as controls . All volunteers 
were on their usual diet and activities . The collection of 
urinary fractions was carried out on an outpatient basis in 
spring time within a period of 45 days in order to avoid 
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seasonal variations of the parameters of interest. From 
each subject, an 17-h daily urine (d) and a 7-h overnight 
fraction (n) were collected. The samples were frozen and 
stored at -70 to -80°C up to further analysis. The crystal 
growth rate of CaOx, Ver, was determined in undiluted 
samples of urine after thawing and centrifugation, at origi-
nal pH, and after adjustment to pH 5.0 . In addition, pH and 
total concentrations of calcium, magnesium, sodium, potas-
sium, phosphate, sulfate, citrate, isocitrate, creatinine, 
urate , oxalate and ammonium were determined . From these 
parameters, saturation ratios (activity product/solubility 
product) of CaOx, uric acid and brushite were estimated 
using a corresponding computer program (Achilles and 
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Figure I 3: Comparison of crystal growth rates of CaOx, 
Ver, in 17-h daily (d) and 7-h nocturnal urine collection (n) 
of 20 male recurrent CaOx stone formers (SF) and 29 
matched normal controls (NC). 
Some of the experimental results are summarized in 
Table 2. In Figure 13 , individual measuring values of Ver in 
the two urinary fractions from SF and NC are demonstra-
ted. The following may be derived from these data : Among 
all parameters under investigation, the Ver determined by 
the GCM showed the largest difference between SF and NC. 
Significantly higher concentrations of Ca and lower concen-
trations of thermodynamic and kinetic effectors of CaOx 
crystal growth were responsible for the higher crystal 
growth rates in SF compared to NC. The results demon-
strate that the parameter Ver is clearly indicative of the 
risk of stone formation and unambigiously superior to 
calculated saturation ratios (Table 2 ). However, though the 
mean values or medians of Ver differ highly significantly 
between the corresponding groups, individual values overlap 
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Table 2. Relative crystal growth rate of CaOx (Ver), satura-
tion ratio (S[CaOx]), and other parameters in 17-h daily (d) 
and 7-h nocturnal urinary fractions (n) of 20 male recurrent 





























Formers (SF) (NC) 
0.73 ± 0.58 
0.63 ± 0.58 
7.31 ± 3.55 
6.04 ± 3.49 
6.04 ± 0.51 
5.72 ± 0.56 
4.81 ± 2. 17 
4.31 ± 2.63 
3.29 ± 1.39 
3 .47 ± 1.86 
17 4 ± 54 
158 ± 71 
46 .4 ± 17.1 
36.7±21.9 
0 .21 ± 0.22 
0.24 ± 0 .25 
4.72 ± 2.25 
5.40 ± 3.43 
SF/ SF NC 
NC din din 
*** n.s. n.s. 
** n.s. n.s . 
n.s. 
6.06 ± 0 .56 n.s. • 
5.68 ± 0.4 7 n.s. 
n.s. 
3.37 ± 1.66 
3.55 ± 1.73 n.s. 
n.s. 
3.66 ± 1.65 n.s. n.s. •• 
4.65 ± 2.04 * 
209 ± 44 
203 ± 62 
61.7 ± 19.3 





0.32 ± 0.13 0.34 ± 0.1 3 n.s. • n.s. 






2.33 ± 0.96 
2.01 ± 1.02 
0 .34 ± 0 .10 
0 .31 ± 0 .13 
2.52 ± I .OS n.s. n.s. n.s. 
2.40 ± I. I 9 n.s. 
0.44 ± 0 .15 
0.48 ± 0.20 
n.s. n.s. 
20.3 ± 6.00 23 .1 ± 7 .61 n.s. n.s. •• 
20.5 ± 8 .07 27.1 ± 8.90 
22 . 1 ± 7 .35 25.0 ± I 0. 9 n.s. n.s. ••• 
22 .2 ± 8.59 35.6 ± 13.7 *** 
Ca, Mg, Na, K, Ox, Cit, i-Cit, SO4, PO4 ... (T) - total 
concentrations of calcium, magnesium, sodium , potassium, 
oxalate, citrate, isocitrate, sulfate, and phosphate (given in 
mM). * p<0.05; •• p<0.01 ; *** p<0.001 corresponding to 
appropriate statistical tests . 
considerably (Figure 13). This leads to the conclusion that 
other factors of urine than those which determine the 
crystal growth should additionally account for the genesis 
of CaOx stone formation. 
Stud ies on the Efficacy of Therapeutical Measures 
All measures of prevention of urolithiasis known up 
to now principally are aimed at reducing the growth rate of 
stone-forming crystal phases. This may be achieved by 
decreasing corresponding supersaturation (thermodynamic 
1010 
effects) or via interactions of effectors on crystal surfaces 
causing growth inhibition (kinetic effects) . Both of them , 
with respect to CaOx, are reflected by the parameter Ver 
(except the influence of urinary oxalate, which must be 
taken into account in another way). Therefore, the GCM 
has been applied to study the efficacy of different medica-
tions proposed as prophylactic measures in CaOx stone 
formation . All pilot studies described below were carried 
out in the same manner. The principal schedule is demon-
strated in Figure 14. During a first period (A; without 
treatment) the 6-8 subjects included in a study were taking 
their usual diet which was explored in detail using a special 
questionnaire . At the 2nd and 3rd day of this period they 
collected a series of urinary fractions . Subsequently, a 
prescribed dose of a drug preparation was given daily up to 
the end of period B. In this period (day 9 to 11) the sub-
jects kept the same diet in quality and quantity of nutrition 
and fluid intake as in period A, and followed the same 
normal habits . Corresponding urinary fractions in B were 
collected as mentioned above. The relative crystal growth 
rate of CaOx and a number of other parameters were 
determined in all urinary fractions before and during treat-
ment. 
THERAPY none preparation under regard 
DOSAGE corresp. to prescription 
free 
DIET docum . free 
corresp. 
to period A 
PERIODS 
TIM E (DAYS) 
1 
. 
3. 4 . 8 . 9. 11. 
Figure 14 : Treatment schedule for in-vivo tes ts of differ-
ent preparations with respect to their effects on parame-
ters of crystal formation in urine. A and B: periods of 
collections of urinary samples. 
Sodium Potassium Citrate . Applying a daily dose of 
3x 11 mmol of this preparation, the mean relative crystal 
growth rate of CaOx, Ver, measured in the whole urines of 
6 healthy male vo lunteers could be decreased by about 70% 
during medication (Achilles et al., I 990). Predominantly , the 
effect could be accounted for by the alteration of three 
urinary parameters: decrease of calcium output, increase of 
citrate, and increase of pH. As could be derived from the 
relationship Vcr=f(CaT ,MllT ,Ci tT ,pH) (Equation 3), the 
change of total Ca during therapy was most effective with 
respect to the reduction of the crystal growth rate . It 
caused more than 50 % of the total decline of Ver while 
simultaneously increasing citrate and pH each accounted for 
20-25 % of the effect. In contrast to the pronounced 
in-vivo effect of the preparation on the crystal growth 


















Figure 15: Effect of sodium potassium citrate therapy 
(daily dose: 2x2. 9 g) on the crystal growth rate of CaOx 
(Ver) and other parameters in 24-h urinary collections of 6 
male healthy volunteers. A: without therapy; 8 : during 
therapy .*: p<0.05; ***: p<0.001. 
rate, a decrease of only 30% could be observed for the 
relative saturation ratio of CaOx. The most important 
parameters with respect to the formation of CaOx regarded 
in this study are summarized in Figure 15 . 
Magnesium Therapy. Since the basic investigations of 
Hammarsten (1936) on the solubility of CaOx in the pre-
sence of Mg(2+ ), this ion has long been supposed to exert a 
beneficial effect also in the prevention of CaOx stone 
formation, e.g. (Johansson et al., I 980) . In order to prove 
this, we carried out an in-vivo s tudy with the following 
Mg-containing preparations (the quantities of the constitu-
ents given here refer to the daily dosage of 12-13 mmol 
Mg applied in the study): I: 1830 mg Mg citrate, 90 mg 
Mg laevulinate, 2 mg vitamin Bl nitrate, 3 mg vitamin 82, 
3 mg vitamin 86, 200 mg citric acid; II: 1840 mg Mg 
citrate trihydrate, 800 mg Mg L-hydrogenglutamate, 40 mg 
Mg nicotate ; III: 307 4 mg Mg L-aspartate hydrochloride. 
The evaluation of the most relevant parameters obtained 
from 24-h urinary collections of 7 male healthy vo lunteers 
before and during therapy is demonstrated in Figure 16. 
The results show that the preparations applied do not 
decrease the crystal growth parameter Ver. On the con -
trary, Mg-aspartate hydrochloride, which shows a marked 
acidifying effect on urine, enhances the crystal growth rate 
of CaOx significantly (p<0.05) . Again, the results may be 
interpreted by our results described above (effects of 
calcium, magnesium, citrate and pH; Equation 3). All prepa -
rations cause a significant increase of urinary magnesium 
and, in part (I and II), of citrate. However , the Ver-decrea-
sing effects of these alterations are compensated, or even 
overcompensated, by the opposite influence of simultaneous 
increase of urinary calcium and (with Ill) decline of pH. 
Thus, the physico-chemical effect of Mg(2+) on the Ver 
known from in-vitro measurements is abolished in-vivo by a 












Figure 16 : Effect of 3 different magnesium preparations on 
the crystal growth rate of CaOx (Ver) and other parame-
ters in 24-h urinary collections of 7 healthy volunteers. 
Each column corresponds to the following period of col-
lection . A: without application (=contro l period); 8,C,D : 
during therapy with preparations I, II, and III, respectively . 
*: p<0.05; **: p<0 .01 ; ***: p<0.001. 
Fiber Preparation (Farnolith(R)). Dietary fibers have 
been supposed to be useful in preventing the recurrence of 
stone formation, e.g. (Griffith et al., I 981; Jarrar et al., 
I 984) . Farnolith(R) (Hesse et al., I 987) is a mixed prepara-
tion of wheat and soya brans, with a high content of 
cellulose, enriched with potassium, magnesium, iron , and 
zinc. In a study with 7 male healthy volunteers, the prepara-
tion was tested in the same manner as described with alkali 
citrate and magnesium compounds. The daily dose was 
2xl 5g. As the most essential parameter, the relative crystal 
growth rate of CaOx was determined in 3-h fractional and 
24-h urine samples before and during application . No signifi-
cant decrease of Ver could be demonstrated administrating 
the preparation. This lack of a benificial action could be 
interpreted again by counteracting effects of Ver-decreasing 
(i.e., decline of calcium excretion) and increasing factors 
(i.e., decrease of the crystal growth inhibitors citrate and 
phosphate) in the urinary samples under investigation 
(Achilles et al., unpublished results). 
Discussion 
In this paper, an optical micro technique has been 
described which allows the efficient determination of rela-
tive growth rates of sparingly soluble crystal phases in gel 
matrices (Gel Crystallization Method; GCM) (Achilles 1984, 
I 985, I 987, I 989). It has been predominantly applied to 
investigate the crystal growth of CaOx and its potential 
role in the genesis, diagnosis and medical therapy of urinary 
stone formation (Achilles et al., I 985b , I 986 , I 989a, 
I 989b, I 990). 
Compared to conventional methods measuring crystal 
growth in solutions or suspensions, e.g. (Baumann, 1988; 
Fleisch, 1985 ; Meyer and Smith, 1975 ; Sheehan and Nan-
collas, I 980; Will et al., I 983) the GCM shows a number 
of advantages. It is characterized by high efficiency and 
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small measuring volume. For example, by conventional 
methods about IO crystal growth curves may be registered 
per day using a mean test volume of at least I 00 ml. By 
comparison, applying the GCM I 20 growth curves may be 
measured per hour employing only 0.2 ml solution per test. 
Irrespective of this features, the reproducibility of the 
crystal growth parameter Ver (CV < ±2 % at standard 
conditions) is comparable to or better than that of crystal 
growth rates obtained by macromethods (Baumann, I 988). 
A comparison of our model to other ones evaluating 
crystal growth in gel matrices, e.g. (LeGeros and Morales, 
I 97 3; Hunter et al., I 986; Rao et al., I 988; Mandel et 
al., I 990), is difficult because in none of these techniques 
growth is induced by seed crystals. Therefore, heteroge-
neous nucleation by the gel matrix, which need not be taken 
into account in the GCM, plays a role in these models. 
Furthermore, times of reaction and observation, as well as 
number and distribution of crystals are quite different 
compared to our method . 
The GCM has been used to quantify the effects of 
different parameters on the crystal growth of CaOx under 
conditions relevant to stone formation . A number of basic 
results cou ld be obtained with respect to the influence of 
urinary constituents on the crystal growth of CaOx. The 
mechanisms underlying the action of relevant parameters 
like calcium, magnesium, citrate, phosphate, and pH, and 
their interaction s could be clarified and differentiated as 
being of thermodynamic and/or kinetic nature. 
The GCM may be directly applied to natural urine 
samples. Here, the quantity Ver reflects the net effect of 
thermodynamic and kinetic factors of whole urine except 
oxalate on the crystal growth of CaOx. The comparison of 
the crystal growth rate of CaOx measured in native urines 
and correspondingly composed artificial ones revealed a 
constantly lower Ver of about 0.17 in the natural samples. 
Because this can not be caused by growth inhibition, a 
thermodynamic reason should account for the difference. 
An unknown binding capacity for Ca(2+), as stated by 
Hodgkinson (I 980), seems to be unlikely. This interpreta-
tion would be in contrast to the findings of Daniele and 
Marangella (I 982), who could show a reasonable agreement 
between free Ca(2+) in urine calculated from complex 
chemical equilibria and measured electrochemically. Possibly, 
the partly reduced Ver in native urine could be accounted 
for by an influence of (unidentified) urinary constituents on 
the crystal phase formed. For instance, a preferred forma-
tion of COD (and/or COT) from natural urine compared to 
a prevailing growth of COM from the artificial samples 
could be responsible for the difference under regard. The 
effects of substances causing changes of crystal habits or 
phase transformation are well known (e.g. Akbarieh and 
Tawashi, I 990; Campbell et al., I 989; Nancollas, I 982). 
However, the hypothesis has to be proven by further 
experiments. Apart from the small difference discussed here , 
the crystal growth rate of CaOx in urine seems to be 
mainly governed by low molecular weight compounds . In 
different kinds of experiments, urinary macromolecules 
could not be found by us to exert remarkable effects on 
the Ver under the conditions applied in this study. Our 
findings are in reasonable agreement with those of Sutor et 
al. (I 97 9) . They demonstrated the anionic urinary cons ti tu-
ents citrate, isocitrate and pyrophosphate to be the major 
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inhibitors of CaOx precipitation in their system. Glycos-
aminog lycans made no contribution to the inhibition of 
CaOx formation in their assay used. However, these results 
are in contrast to those of other reports on the role of 
macromolecules in CaOx crystal growth, e.g. (Edyvane et 
al., I 987; Lanzalaco et al. I 988). Comparative studies are 
highly desirable in order to assess the value of different 
crystal growth models under compatible experimental 
con di !ions . 
The rationale of any existing prophylaxis in recurrent 
CaOx urolithiasis is the reduction of the growth rate of 
CaOx in the patient's urine . As has been mentioned already 
above, this may be achieved by lowering CaOx supersatura-
tion , e.g., via the reduction of Ca and/or oxalate excretion 
or increased diuresis , and/or by an increase of urinary 
inhibitors like citrate or pyrophosphate. Therefore, the 
Ver seems to be an ideal parameter to follow up the effi-
cacy of therapeutical measures aimed at reducing the crystal 
growth of CaOx. As could be shown by the studies de-
scribed above, the application of alkali citrate was most 
effective with this respect. The simultaneous decrease of Ca 
output, and increase of urinary citrate and pH were acting 
in the same direction of a desired decline of crystal growth 
(Achilles et al., I 990). These findings explain the beneficial 
effect of alkali citrates in the prevention of recurrent CaOx 
stone formation (Pak et al., I 981; Preminger et al., I 985a , 
I 985b). On the other side, no or even an adverse influence 
on the parameter Ver cou ld be detected in human urine 
applying Mg-containing preparations (Tischmann et al., 
I 987) . The results account for the lack of a beneficial 
effect in the prevention of CaOx urolithiasis by Mg ther apy 
as demonstrated by Ettinger et al. (I 988) in a controlled, 
double-blind therapy study. Furthermore, it could be shown 
by our investigation that the counterion of Mg(2+) (e.g., 
citrate or aspartate hydrochloride) may significantly affect 
the crystal growth rate in urine. 
The rationale for the application of fiber preparations 
to prevent recurrent CaOx stone formation refers to their 
Ca-absorbing properties aimed at the reduction of CaOx 
supersaturation in urine. However, as could be shown by 
our study with the preparation Farnolith(R), simultaneous 
alterations of other effectors result in a negligible net 
effect on the crystal growth of CaOx during therapy. Thus , 
fiber preparations might be of use only in patient s with 
intestinal Ca hyperabsorption as stated by others (Stroh-
maier et al., I 989). In conclusion, the parameter Ver meas-
ured by the GCM is a suitable diagnostic mean in order to 
control the efficacy of therapeutical measures with respect 
to the crystal growth of CaOx in urine of patients suffer-
ing from urolithiasis. It may be clinically applied and is also 
suitab le to select responders from nonresponders, or 
compliers from noncompliers undergoing a certain pro-
phylactic therapy . With this respect, the Ver is clearly 
superior to the calculated supersaturation of CaOx (S) in 
urine which is often used as a criterion for the risk of 
stone formation. While S represents only the thermodyna -
mic driving force for crystallization, the growth parameter 
Ver, additionally, reflects kinetic effects on the crystal 
surface . 
The application of the GCM to study the crystal 
growth of CaOx in urinary fractions of the two groups of 
male recurrent CaOx stone formers and carefully matched 
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normal controls described above revealed a highly significant 
difference of the Ver between the two groups under regard 
(Achilles et al., 1991 ). However, the overlap of correspon-
ding individual values also demonstrates that other factors 
than those which govern the crystal growth rate should 
additionally be responsible for the genesis of CaOx stone 
formation. This means that the 'crystallization theory' of 
stone formation, e.g. (Robertson, I 982) can be confirmed 
by our study only in part. Increased crystal growth caused 
by hypercalciuria and other effectors of crystallization can 
be contributing but not sufficient factors causing urolithia-
sis. Obviously, phenomena like crystal agglomeration 
(Edyvane et al., I 987; Kok et al. , I 990) and/or adherence 
(retention) on biological surfaces (Khan et al., I 990; Fin-
layson , I 982 ; Riese et al. , I 988) must be taken into regard 
in order to account for the genesis of stone formation. 
Here, the macromolecular Tamm-Horsfall-Mucoprotein 
seems to be likely to act as a promotor of CaOx crystal 
agglomeration (Rose and Sulaiman, I 982; Rose, I 986) . 
Recently, the group of Nancollas (Campbell et al. , I 989) 
has stressed the dual role of polyelectrolytes as mineraliza-
tion promotors when immobilized on surfaces , and as 
crystallization inhibitors when present in solution, which 
should be taken into consideration in further studies on the 
cause of stone formation. These facts, at least in part , 
support the 'matrix theory ' (Boyce and Garvey , 1956 ; 
Khan et al. , I 983 ; Khan and Hackel , I 987; Morse and 
Resnick, I 988) . 
With respect to crystal growth of CaOx, the GCM 
described here seems to simulate physiological conditions of 
urinary stone formation better than studies carried out in 
aqueous solution . Regarding the results of Iwata et al. 
(I 985, I 986, I 989), growth of urinary stones occurs in a 
gel-like state. The gel, which covers the stone mineral as a 
mucinous layer, is encrusted by further crystalline material 
thus forming the later stone matrix. Hering et al. (I 987) 
have detected in human kidneys by scanning electron micros-
copy crystalline particles which were embedded and fixed in 
mucinous material. Khan and Hackel t (I 987) could show 
that even single crystals in human urine are covered by 
organic material. With this respect , laws of crystallization 
in gel matrices as detected by the group of Pucar (Srzic et 
al., I 97 6) and theoretically interpreted by Nielsen et al. 
(I 977) should also be of relevance with respect to stone 
growth. Moreover, it should be taken into account that 
concentrations of macromolecular inhibitors like glycos-
aminoglycans, in the medium of stone growth, i.e. matrix 
material, are by some orders of magnitude higher (Fraj, 
I 989; Nishio et al. I 985; Roberts and Resnick, I 986) than 
in urinary solution (2-1 0 mg/I) (Michelacci et al., I 989). At 
those concentrations (> I g/1), GAGS could also be found to 
reduce significantly the crystal growth of CaOx in our gel 
model. Therefore, it may be concluded that GAGS might 
protect the urinary tract from pathological mineralization 
as highly enriched constituents of the stone matrix rather 
than as soluble compounds . 
Regarding the principal ability and limits of the gel 
crystallization method discussed in this paper, the following 
has to be mentioned. The measuring parameter of this 
method (Ver) is a relative, empirical quantity which has not 
been related yet to an absolute crystal growth rate. For 
this reason, basic research must be done in order to inter-
pret theoretically the optical measuring curves, e.g., in 
terms of particle size and particle distribution within the gel 
matrix . Scattered light, which is used to detect the growth 
of crystals, is related to the mean size of particles . Under 
the conditions applied for CaOx so far, these consist of a 
mixture of different calcium oxalate hydrates, predomi-
nantly COM. In principle, applying polarized light to follow 
the crystal growth in gels , the birefringent crystal phase 
COM should be detectable separately. However, this mode 
of measurement has been tested yet only in preliminary 
experiments and must be evaluated in detail. Keeping to the 
conditions of metastability in a gel system used, the para-
meter Ver reflects pure crystal growth excluding nucleation 
and agglomeration . The model is not suitable to evaluate 
the phenomenon of crystal adhesion or retention which 
might be of considerable importance in the genesis of 
urolithiasis . Taking this into account, it seems to be an 
important task in future to create a model of crystalliza-
tion which simulates the process of stone formation by 
combining a flux of urine with a gel matrix in order to 
observe and to evaluate crystal nucleation, adhesion and 
agglomeration in addition to growth . 
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Discussion with Reviewers 
G. Mandel: Why is your Ksp for CaOx different from that 
determined by Tomazic and Nancollas? 
Wolfgang Achilles 
Author: The solubility product estimated in this study is an 
apparent one. It was derived from Ver = f(CaT). Possibly , 
the extrapolation of this function to CaT at Vcr=0, toge-
ther with the detection limit of the optical method measur-
ing crystal growth, might be responsible, at least in part, 
for an overestimation of the "Ksp" . However, further 
research has to be done to give a more satisfactory answer 
to this question . 
G. Mandel: The description of Figure 6 is hard to follow. 
What is the significance of the differences observed bet-
ween the Ver and S/SN curves ? Why are the slopes of the 
experimental and calculated curves so different for PO4 in 
Figure 9? 
Author: S/SN has been defined as a term which is under 
certain conditions compatible with Ver. With respect to the 
variation of CaT in the standard solution (Vcr=f(CaT)) 
both parameters should have at least two common points: 
I. at AP=Ksp --> S/SN=Vcr=0, and 2 . at AP=APN --> 
S/SN=Vcr= I. Significant differences between the course of 
S/SN and Ver (as seen from Figure 9) give an estimate of 
the kinetic nature of an effect exerted on the crystal 
growth rate , i.e. , phosphate affects the crystal growth 
rather via its surface action than by decreasing Ca(2+) via 
ion pair formation. 
S .R. Khan: I would like to see the composition of agar that 
is being used for making the gel. Is the gel totally inert ? It 
has often been said that any particulate material can insti-
gate crystal nucleation in a metastable solution . Can the 
agar used in this study act as a heterogeneous nucleator? 
Some of the agars may contain macromolecules that can be 
inhibitory to crystallization. 
Author : We used gels like agar-agar, agarose (carbohydra-
tes) and gelatine (protein) to compare crystal growth in 
different matrices. Concentrations of the gels were very 
low (e.g., 0.5 % for agar), resulting in matrices which were 
near to the liquid state . Using the same measuring conditi-
ons, growth curves obtained with different gels resulted in 
different absolute quantities of scattered light and increase 
of light intensity per time . However, the differences disap-
peared when slopes had been referred to the same standard 
as done by calculation of the parameter Ver. Thus , potential 
effects of the gel matrix on absolute crystal growth rates 
seem to have no significant relevance in comparative meas-
urement. Heterogeneous nucleation of crystals by the gel 
matrix can be absolutely excluded as to our conditions of 
seeded crystal growth . Principally, experiments were perfor-
med below the limits of metastability, which had been 
determined previously in gels without seed crystals. 
S.R. Khan: It is pointed out in the manuscript that during 
urolithiasis crystals grow in a gel-like "mucinous macromo-
lecular" layer. What is the nature of this layer ? What is the 
thickness of such a layer ? ls the author suggesting that 
that is the only way for matrix to be incorporated into the 
stone ? 
Author : As to the growth of stone mineral in a gel-like 
state I refer to the findings of Dr.Iwata from Japan. His 
group interprets radially oriented crystal growth in stones 
1016 
as a process which can only take place in a gel-like medium. 
The mucinous macromolecular layer covering a stone must 
have a composition which is very similar to or even like 
that of the stone matrix. Its thickness may be between 0.1 
and some micrometers. This can be estimated from SEM 
results on microcrystals in human kidneys as shown by the 
group of Dr. Hering from Switzerland. It is in a good 
agreement with the thickness of the layer which may be 
derived from OM and SEM photographs of stone material 
by Dr.Iwata (personal communication). I do not know 
whether the growth of crystalline material within this 
gel-like state is the only way for matrix to be incorporated 
into the stone . However, it seems to be a very obvious 
mechanism. 
S.R. Khan: I would like the author to comment about the 
porosity of the gel. Would urinary macromolecules, some 
of which can be pretty large, be able to travel through the 
gel? 
Author: Referring to data given by Henisch et al., the large 
pores of light gels as we use them should exceed 5 µm in 
diameter. The mean diameter of macromolecules of up to 
I o5 d can be estimated to be about three orders of mag-
nitude smaller. Corresponding to a personal communication 
of Dr.Pucar from Zagreb , who has done a lot of work on 
crystallization in gels, molecules of a molecular mass of up 
to I 06 d should be freely diffusible in those light gels . 
However , large aggregates of THMP as they are formed at 
high ionic strength should be excluded from diffusion into 
the gel matrix . 
S.R . Khan: Whole urine is generally frozen and then thawed 
for the determination of Ver. What would be the effect of 
freezing and thawing on the macromolecules ? 
Author: We have not tested this up to now. However , 
because macromolecules of urine could not be found to 
affect the crystal growth of Caox significantly in the 
model, I suppose that potential alterations of this fraction 
by freezing and thawing should not be of remarkable influ-
ence on the measuring parameter Ver, too. 
H. Iwata: Urinary macromolecules, especially glycosamino-
glycans, are believed to inhibit the crystal growth mainly by 
covering the crystal surface, thereby blocking the growth 
site (kinetic effect in your words). I wonder if this inhibi-
tory effect of glycosaminoglycans may be underestimated in 
the gel system because of the retarded diffusion of the 
macromolecules through the gel ? 
Author: At first I should like to refer to my answer to a 
similar question of Dr.Kahn regarding the effect of macro-
molecules in gels. With the exception of very large aggrega-
tes like polymeric THMP, retarded diffusion of urinary 
macromolecules through the gel should not be responsible 
for an underestimated effect of inhibition. I would rather 
suppose that the seed crystals within the gel are connected 
to structures of the matrix. Thus, they may not, or only in 
part, be accessible to larger molecules. Further work has to 
be done on this problem. 
R. Tawashi and M. Akbarieh: Your figures show the growth 
rate between 0 to 15 minutes. This period is too short for 
Microdetermination of Crysta l Growth in Gel 
the growth stud ies especially if the author is planning for a 
future model for stone formation. What happens if growth 
is ex tended over days ? 
Author: I agree with the reviewers that a longer period of 
crystal growth and observation is desirable for future 
models of stone formation. However, the experimental 
conditions in the model presented here were optimized with 
respect to the detection limit and sensitivity of the optical 
mode of measurement in order to gain sufficiently repro-
ducible results (slopes of crystal growth curves). The rather 
short periods of growth and observation are a consequence 
of this optimization which leads to the high efficiency of 
the method. However, the influence of relevant effectors 
on crystal growth may be clearly recognized under these 
conditions. If growth is extended over days the crystal 
image is governed by equilibrium conditions rather than by 
kinetic ones. The measuring signal reaches a maximum which 
is difficult to interpret because of superimposing crystals 
within the gel. 
R. Tawashi and M.Akbarieh: If figure 16 is true regarding 
the Ver, what is the author's response to the many clinical 
reports published on the beneficial effects of Mg(2+) in 
urolithiasis? 
Author : As far as I know, with respect to the in-vivo 
effect of magnesium preparations on CaOx stone recur-
rence, there are only one or two corresponding clinical 
studies which may be denoted as being reliable, because they 
followed a controlled, double-blind protocol. Referring to 
these results (Ettinger et al.), no beneficial effect of magne-
sium has been proved. This is in agreement with our fin-
dings. 
G.Mandel: The observation that natural urine had a Ver 
0.1 7 below that of synthetic solutions was attributed to 
possible changes in CaOx crystal diamorphs. This possibility 
can easily be tested by taking scanning micrographs of the 
crystalline products formed under the various conditions. 
Author: Up to now we have not used SEM in parallel to 
kinetic experiments because the method is not available in 
our laboratory and because we have focussed our work to 
kinetics at first. However, I agree with you that a supp le-
mentation of micrographs could be fruitful in order to 
clarify some open questions in the paper. I shall take the 
comment into regard in our future work. 
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G.Mandel: The author has stated that " the Ver is clearly 
super ior to the calculated supersaturation of CaOx ... as a 
criterion for the risk of stone formation ." However, 
Figure 13 shows that only 7(d) or 6(n) of 20 stone for-
mers have Ver values outside the range of stone formers. 
Since these Ver values are very significantly different from 
the non-formers , the statistics are skewed. The wide varia-
tion in Ver values for stone formers is also evident in Table 
2. The standard deviations in Ver values for stone formers 
are 79% (d) and 92%(n) of the actual Ver value, whereas 
the standard deviations in S for the same stone formers are 
only 48 % (d) and 58 % (n). This would suggest very wide 
var iation in Ver values. This would further suggest that the 
number of stone formers having a Ver value within the 
range of non-formers is greater than the number of stone 
formers having a S values within the range S for non-for-
mers. 
Author: There are a series of reasons to state that the 
parameter Ver is superior to the calculated supersaturation 
of CaOx. a) The ratios of the means of Ver in SF and NC 
(Table 2) were 0.7 3/0 .21 =3.5 (p<0.00 I) in daily urine and 
0 .63 /0.24=2 .6 (p<0.05) in overnight co llections . Compara-
tive values for S(CaOx) were 7.31/4.72=1.5 (p<0.01) and 
I . I (n.s.). The skewness of the distribution of Ver has been 
regarded in the statistics. b) The effect of therapeutic 
measures, e.g . with alkali citrate, could be clearly detected 
by the crystal growth (decrease of more than 70% during 
therapy). In comparison, S(CaOx) dropped only by 33 % 
(Achilles et al. I 990: Urol.Res. 18, 1-6) . c) The crystal 
growth rate may be measured very efficiently by a single 
analytical procedure. The calculation of S(CaOx) requires 
the determination of 8-1 0 different analytical parameters . 
d) Direct (e.g. by pyrophosphate) or indirect (e.g. by pH) 
kinetic effects may only be detected by crystal growth 
rates. 
G.Mandel: Could you provide additional data on the number 
of seed crystals per unit area or volume? 
Author: We have tried to make an estimate of the number 
of seeds per volume by several techniques. However , it has 
not been possible up to now to obtain reliable results . 
Probably , image analysis of SEM-images may provide the 
desired quantity . 

